Original Article

Vitamin D receptor (BsmI) genotypes influence inflammatory and oxidative stress responses to altered vitamin D intake in subjects with Type 2 diabetes: A randomized controlled trial


Background: The purpose of our study was to investigate the possible effect of BsmI vitamin D receptor (VDR’s) polymorphism on changes of the inflammatory and oxidative stress (OS) biomarkers in response to daily intake of vitamin D- fortified yogurt drink (doogh) in subjects with type 2 diabetes (T2D).
Methods: In a randomized controlled trial, 100 T2D subjects were allocated to two groups to receive either plain doogh (PD; n = 50, containing 170 mg calcium and no vitamin D/250 ml) or vitamin D3-fortified doog(FD; n = 50, containing 170 mg calcium and 500 IU/250 ml) twice a day for 12 weeks. 25(OH)D, glycemic status, inflammatory as well as OS biomarkers were evaluated before and after the intervention. VDR-BsmI genotypes in an extended number of T2D subjects in the FD group (n = 140) were determined as BB, Bb, and bb.
Results: After 12 weeks, in FD compared to PD, serum 25(OH)D increased (+30.0 nmol/l vs. −4.8 nmol/l, p < 0.001). The 25(OH)D, parathyroid hormone, highly sensitive C-reactive protein (hs-CRP), malondialdehyde (MDA), and glutathione (GSH) in patients with the BB genotype were more responsive to vitamin D intake in which the maximum increment in 25(OH)D was in BB (31.8 nmol/l) compared with  Bb  (24.4  nmol/l)  and  bb  (20.8  nmol/l)  (p  for  trend  <  0.001),  and  the difference in BB, compared to Bb and bb was significant [Bb (p = 0.024) and bb (p = 0.037)]. This difference was accompanied by a significant difference for other biomarkers including fasting serum glucose (p trend = 0.039), fat mass % (p trend < 0.001), interleukin 6 (p trend = 0.033), hs-CRP (p trend < 0.001), and MDA (p trend = 0.028) which significantly all decreased in BB genotype except for GSH which significantly increased (p trend = 0.035).
Conclusion:  Daily   intake   of   vitamin  D-FD   for   12   weeks   improved   the inflammatory and OS biomarkers in T2D subjects, and the improvement was more pronounced in the carriers of BB genotype of VDR-Bsm.

Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol. 2004; 44(4): 397-405.

Holick MF. Vitamin D deficiency. N Engl J Med.2007; 357(3): 266-81.

Johansen JS, Harris AK, Rychly DJ, Ergul A.Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005; 4: 5.

Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Kalayi A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012; 28(5): 424-30.

Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD.Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med. 2010; 123(4): 335-41.

Crowley SD. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 2014; 20(1): 102-20.

Ding C, Gao D, Wilding J, Trayhurn P, Bing C.Vitamin D signalling in adipose tissue. Br J Nutr.2012; 108(11): 1915-23.

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down- regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006; 36(2):361-70.

Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab.2011; 13(1): 11-22.

Riachy R, Vandewalle B, Kerr CJ, Moerman E, Sacchetti P, Lukowiak B, et al. 1,25- dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology. 2002; 143(12): 4809-19.

Jain SK, Manna P, Micinski D, Lieblong BJ,Kahlon G, Morehead L, et al. In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress? Antioxid Redox Signal. 2013; 18(10): 1154-8.

Noyan T, Balaharoglu R, Komuroglu U. The oxidant and antioxidant effects of 25- hydroxyvitamin D3 in liver, kidney and heart tissues of diabetic rats. Clin Exp Med. 2005; 5(1):31-6.

Mutt SJ, Hypponen E, Saarnio J, Jarvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014; 5: 228.

Vuolo L, di Somma C, Faggiano A, Colao A.Vitamin D and cancer. Front Endocrinol (Lausanne). 2012; 3: 58.

Xiao XH, Liu ZL, Wang H, Sun Q, Li WH, Yang GH, et al. Effects of vitamin D receptor gene polymorphisms on susceptibility to type 1 diabetes mellitus. Chin Med Sci J. 2006; 21(2):95-8.

Al-Daghri NM, Guerini FR, Al-Attas O, Alokail MS, Alkharfy KM, Draz H, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One.2014; 9(7): e102141.

Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC.Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012; 18(14): 1672-9.

Elnenaei MO, Chandra R, Mangion T, Moniz C.Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation. Br J Nutr. 2011; 105(1): 71-9.

de Medeiros Cavalcante IG, Silva AS, Costa MJ, Persuhn DC, Issa CI, de Luna Freire TL, et al. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. Exp Gerontol. 2015; 66:10-6.

Neyestani TR, Djazayery A, Shab-Bidar S, Eshraghian MR, Kalayi A, Shariatzadeh N, et al. Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care. 2013; 36(3): 550-6.

Shab-Bidar S, Neyestani TR, Djazayery A. The interactive effect of improvement of vitamin D status and VDR FokI variants on oxidative stress in type 2 diabetic subjects: a randomized controlled trial. Eur J Clin Nutr. 2015; 69(2): 216-22.

Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double- blind clinical trial. BMC Med. 2011; 9: 125.

Neyestani TR, Gharavi A, Kalayi A.Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res. 2007;77(5): 341-6.

Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002; 87(1):144-7.

Neyestani TR, Gharavi A, Kalayi A. Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr. 2009;60(Suppl 1): 79-88.

Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest. 2007; 30(10): 833-8.

Ye WZ, Reis AF, Velho G. Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene. J Hum Genet. 2000; 45(1): 56-7.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7): 1911-30.

Chen N, Wan Z, Han SF, Li BY, Zhang ZL, Qin LQ. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients. 2014; 6(6): 2206-16.

Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009; 27(10):1948-54.

Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007; 98(Suppl 1): S29-S35.

Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51: 311-36.

Vilarrasa N, Vendrell J, Maravall J, Elio I, Solano E, San JP, et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010; 38(2): 235-42.

Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011; 347(1-2): 106-20.

Gagnon C, Daly RM, Carpentier A, Lu ZX, Shore-Lorenti C, Sikaris K, et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta- cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One.2014; 9(10): e109607.

Ochs-Balcom HM, Chennamaneni R, Millen AE, Shields PG, Marian C, Trevisan M, et al. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93(1): 5-10.

Palomba S, Orio F, Russo T, Falbo A, Tolino A, Manguso F, et al. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial. Osteoporos Int. 2005; 16(8): 943-52.

Kiel DP, Myers RH, Cupples LA, Kong XF, Zhu XH, Ordovas J, et al. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res. 1997;12(7): 1049-57.

Selvaraj P, Chandra G, Jawahar MS, Rani M, Rajeshwari N, Narayanan PR. Regulatory role of vitamin D receptor gene variants of BsmI, ApaI, TaqI, and FokI polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. Journal of Clinical Immunology.2004; 24(5): 523-32.

Arabi A, Zahed L, Mahfoud Z, El-Onsi L, Nabulsi M, Maalouf J, et al. Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone. 2009; 45(6): 1091-7.

Poon AH, Gong L, Brasch-Andersen C, Litonjua AA, Raby BA, Hamid Q, et al. Very important pharmacogene summary for VDR. Pharmacogenet Genomics. 2012; 22(10): 758-63.

Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC.Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem. 2013; 288(27): 19450-8.

IssueVol 1, No 3 (Summer 2015) QRcode
SectionOriginal Article(s)
Vitamin D Oxidative stress Inflammation Type 2 diabetes BsmI polymorphism and vitamin D receptor gene

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Shab-Bidar S, Neyestani T, Djazayery A. Vitamin D receptor (BsmI) genotypes influence inflammatory and oxidative stress responses to altered vitamin D intake in subjects with Type 2 diabetes: A randomized controlled trial. J Nutr Sci & Diet. 2015;1(3):116-126.